Afya (AFYA)
(Delayed Data from NSDQ)
$17.92 USD
-0.02 (-0.11%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $17.94 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth F Momentum C VGM
Price, Consensus and EPS Surprise
AFYA 17.92 -0.02(-0.11%)
Will AFYA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AFYA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AFYA
Afya (AFYA) Suffers a Larger Drop Than the General Market: Key Insights
Afya (AFYA) Laps the Stock Market: Here's Why
AFYA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Lifetime Brands (LCUT) Misses Q4 Earnings Estimates
Toro (TTC) Lags Q1 Earnings Estimates
Afya (AFYA) Stock Slides as Market Rises: Facts to Know Before You Trade
Other News for AFYA
AFYA: Mr Market Is Mistaken
White Brook Capital Partners Q1 2024 Commentary
AFYA Stock Earnings: Afya Beats EPS, Beats Revenue for Q4 2023
Afya Is Performing Well And Is A Buy
Afya Non-GAAP EPS of R$1.79, revenue of R$729.5M; initiates FY24 guidance